UNSPSC 51263014: Trimazosin hydrochloride

This classification denotes the hydrochloride form of an alpha-adrenergic blocking agent with the molecular formula C20H29N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 31L760807H, chemically known as 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-1-piperazinecarboxylic acid, 2-hydroxy-2-methylpropyl ester but more generally known as trimazosin, which bears US NIH Compound Identifier 37264. European Medicines Agency schedules Trimazosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11298MIG.

UNSPSC 51263014 Trimazosin hydrochloride is a Commodity code that shows minimal recent state and local procurement activity directly aligned with its pharmaceutical scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS—is tagged under this code but solicits naloxone and safe drug deactivation systems, not trimazosin hydrochloride. The mismatch suggests either a data classification error or that the code is not actively used by state and local buyers for its nominal pharmaceutical product. State and local health departments and counties that do procure specialty pharmaceuticals and drug-related medical supplies typically issue IFBs or RFPs through county health departments or purchasing offices, often with quarterly or annual delivery schedules and E-Verify and workers' compensation compliance requirements.

The geographic activity is extremely limited. Seminole County, Florida posted the only recent opportunity in the dataset on June 30, 2026, with a response deadline of July 26, 2023 (a historical date, indicating the solicitation has closed). The procurement called for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Given the absence of additional recent opportunities under this code and the mismatch between the code's pharmaceutical name and the naloxone-focused solicitation, this UNSPSC category does not appear to be an active procurement target for state and local buyers at this time.